Cancer cell sensitivity to bortezomib is associated with survivin and p53 status but not cancer cell types

Title
Cancer cell sensitivity to bortezomib is associated with survivin and p53 status but not cancer cell types
Authors
Keywords
-
Journal
Publisher
Springer Nature
Online
2010-01-23
DOI
10.1186/1756-9966-29-8

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started